*Rachel Gemine,1 Keir Lewis2
1. Research and Development, Hywel Dda University Health Board;
College of Medicine, Swansea University, Swansea, UK
2. Department of Respiratory Medicine, Prince Philip Hospital, Hywel Dda University Health Board; College of Medicine, Swansea University, Swansea, UK
*Correspondence to Rachel.Roberts3@wales.nhs.uk
Disclosure: The authors have declared no conflicts of interest.
Received: 01.03.16 Accepted: 29.06.16
Citation: EMJ Respir. 2016;4:86-91.
Smoking is the leading cause of lung cancer (LC) worldwide, however any continuing effects of smoking or cessation following a diagnosis are less well known. With around 40% of patients with LC smoking at the time of diagnosis and the majority presenting with an incurable/progressive disease, should clinicians be strongly recommending smoking cessation programmes? The evidence proposes that they should be. Current literature suggests that stopping smoking following a diagnosis of LC can lead to better treatment responses, fewer treatment complications, and less recurrence or new tumours. These benefits translate into reduced mortality and importantly, better quality of life. This review will look at the growing body of evidence that suggests smoking cessation should be prioritised in patients who have been diagnosed with LC.